Samantha McLemore - Patient Capital Management
Holding/activity history for Precigen, Inc. (PGEN)
← All PGEN superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 17,817,387 | 2.57 | Reduce 4.58% | 0.14 | $3.04–5.47 · VW $4.11i | $68,953,288 | SEC |
| 2025 Q4 | 18,673,466 | 3.01 | Reduce 29.43% | 1.02 | $2.99–5.19 · VW $4.03i | $78,055,089 | SEC |
| 2025 Q3 | 26,460,848 | 3.48 | Add 62.65% | 1.34 | $1.40–5.23 · VW $3.49i | $87,056,189 | SEC |
| 2025 Q2 | 16,268,741 | 1.04 | Reduce 6.35% | 0.08 | $1.11–1.66 · VW $1.43i | $23,101,613 | SEC |
| 2025 Q1 | 17,372,301 | 1.33 | Reduce 2.85% | 0.03 | $1.03–2.17 · VW $1.54i | $25,884,728 | SEC |
| 2024 Q4 | 17,881,246 | 0.92 | Reduce 0.31% | <0.01 | $0.65–1.20 · VW $0.94i | $20,026,995 | SEC |
| 2024 Q3 | 17,937,694 | 0.83 | Reduce 1.30% | 0.02 | $0.90–1.93 · VW $1.25i | $16,988,789 | SEC |
| 2024 Q2 | 18,174,658 | 1.53 | Add 4.13% | 0.06 | $1.20–1.83 · VW $1.47i | $28,715,960 | SEC |
| 2024 Q1 | 17,453,455 | 1.23 | Add 9.20% | 0.10 | $1.19–1.79 · VW $1.46i | $25,307,509 | SEC |
| 2023 Q4 | 15,983,700 | 1.14 | Add 16.22% | 0.16 | $0.84–1.45 · VW $1.17i | $21,418,157 | SEC |
| 2023 Q3 | 13,753,176 | 1.15 | Add 22.32% | 0.21 | $1.05–1.88 · VW $1.49i | $19,529,510 | SEC |
| 2023 Q2 | 11,243,560 | 0.72 | Add 668.13% | 0.63 | $0.96–1.45 · VW $1.19i | $12,930,093 | SEC |
| 2023 Q1 | 1,463,760 | 0.70 | Add 83.38% | 0.32 | $0.81–2.29 · VW $1.45i | $1,551,586 | SEC |
| 2022 Q4 | 798,200 | 0.60 | Add 167.67% | 0.38 | $1.26–2.28 · VW $1.72i | $1,213,264 | SEC |
| 2022 Q3 | 298,200 | 0.32 | $2.12 | $632,000 | SEC | ||
| 2022 Q2 | 298,200 | 0.20 | $1.34 | $400,000 | SEC | ||
| 2022 Q1 | 298,200 | 0.25 | $2.11 | $629,000 | SEC | ||
| 2021 Q4 | 298,200 | 0.45 | $3.71 | $1,106,000 | SEC |
Price snapshot:
Current price$5.17
Avg. buy price$2.07
+/- since buy150.12%
52-week low$1.47
52-week high$6.04